PANTOPRAZOLE T DIN 02466147
Status: Marketed
Holder: SANIS HEALTH INC
Health Canada record
| Active ingredient(s) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM HEMIPENTAHYDRATE) 40 MG |
|---|---|
| Dosage form | Tablet (Delayed-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A02BC02 PANTOPRAZOLE |
| Original market date | 25-Oct-2017 |
| Current status date | 25-Oct-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM HEMIPENTAHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02408570 | MYLAN-PANTOPRAZOLE T | MYLAN PHARMACEUTICALS ULC | Tablet (Delayed-Release) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM HEMIPENTAHYDRATE) 40 MG | Marketed |
| 02519534 | PANTOPRAZOLE MAGNESIUM | SIVEM PHARMACEUTICALS ULC | Tablet (Delayed-Release) | PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM HEMIPENTAHYDRATE) 40 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19529 | 2017-07-13 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |